A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
Clinical trial NCT02886065 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02886065
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2026-09-15
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.